Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 37.53% is in line with its 5-year average of 36.76%, near the low end of its 5-year range (35.03%–45.52%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.46% above its 12-month average of 36.99%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 37.53%.
DEBT TO ASSETS RATIO
37.53%
DEBT TO ASSETS RATIO AVG TTM
36.99%
DEBT TO ASSETS RATIO AVG 3Y
36.29%
DEBT TO ASSETS RATIO AVG 5Y
36.76%
DEBT TO ASSETS RATIO AVG 10Y
53.67%
DEBT TO ASSETS RATIO AVG 15Y
52.46%
DEBT TO ASSETS RATIO AVG 20Y
38.85%
CURRENT VS TTM AVG
+1.46%
CURRENT VS 3Y AVG
+3.41%
CURRENT VS 5Y AVG
+2.11%
CURRENT VS 10Y AVG
-30.08%
CURRENT VS 15Y AVG
-28.46%
CURRENT VS 20Y AVG
-3.41%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 815 covered companies
CURRENT VS SECTOR MEDIAN
+41600.79%
vs the sector median at left
Option Care Health, Inc.
Market Cap
$4.66B
Debt to Assets Ratio
37.53%
TTM Avg
36.99%
3Y Avg
36.29%
5Y Avg
36.76%
Market Cap
$4.66B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.68B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.69B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80B
Debt to Assets Ratio
0.73%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.80B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.46B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.44B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Option Care Health, Inc. (OPCH) | $4.66B | 37.53% | 36.99% | 36.29% | 36.76% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.66B | 0.03% | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.66B | 0.20% | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.68B | 0.00% | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.69B | 0.09% | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.80B | 0.73% | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.80B | 0.00% | N/A | N/A | N/A |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.46B | 0.08% | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.44B | 0.64% | N/A | N/A | N/A |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.39B | 0.41% | N/A | N/A | N/A |
Debt/Assets
37.5%
Debt/Equity
1.01
Current Ratio
1.47
Interest Coverage
5.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 37.53% |
| 2026-03-31 | 37.58% |
| 2025-12-31 | 36.85% |
| 2025-09-30 | 36.67% |
| 2025-06-30 | 36.32% |
| 2025-03-31 | 36.96% |
| 2024-12-31 | 35.60% |
| 2024-09-30 | 35.64% |
| 2024-06-30 | 36.60% |
| 2024-03-31 | 36.03% |
| 2023-12-31 | 35.04% |
| 2023-09-30 | 35.98% |
| 2023-06-30 | 35.03% |
| 2023-03-31 | 37.42% |
| 2022-12-31 | 35.73% |
| 2022-09-30 | 37.61% |
| 2022-06-30 | 39.40% |
| 2022-03-31 | 40.94% |
| 2021-12-31 | 39.63% |
| 2021-09-30 | 44.47% |
| 2021-06-30 | 45.52% |
| 2021-03-31 | 46.93% |
| 2020-12-31 | 43.79% |
| 2020-09-30 | 47.17% |
| 2020-06-30 | 51.55% |
| 2020-03-31 | 52.04% |
| 2019-12-31 | 53.50% |
| 2019-09-30 | 52.30% |
| 2019-06-30 | 91.55% |
| 2019-03-31 | 89.72% |
| 2018-12-31 | 86.43% |
| 2018-09-30 | 86.13% |
| 2018-06-30 | 87.13% |
| 2018-03-31 | 82.03% |
| 2017-12-31 | 79.32% |
| 2017-09-30 | 81.08% |
| 2017-06-30 | 77.83% |
| 2017-03-31 | 78.43% |
| 2016-12-31 | 74.36% |
| 2016-09-30 | 73.27% |
| 2016-06-30 | 73.53% |
| 2016-03-31 | 84.20% |
| 2015-12-31 | 79.41% |
| 2015-09-30 | 79.78% |
| 2015-06-30 | 72.57% |
| 2015-03-31 | 49.54% |
| 2014-12-31 | 51.39% |
| 2014-09-30 | 49.28% |
| 2014-06-30 | 47.38% |
| 2014-03-31 | 46.51% |
| 2013-12-31 | 46.49% |
| 2013-09-30 | 44.87% |
| 2013-06-30 | 30.20% |
| 2013-03-31 | 38.06% |
| 2012-12-31 | 35.24% |
| 2012-09-30 | 34.48% |
| 2012-06-30 | 38.14% |
| 2012-03-31 | 43.23% |
| 2011-12-31 | 43.34% |
| 2011-09-30 | 42.85% |
| 2011-06-30 | 42.40% |
| 2011-03-31 | 42.68% |
| 2010-12-31 | 46.16% |
| 2010-09-30 | 42.83% |
| 2010-06-30 | 44.69% |
| 2010-03-31 | 46.29% |
| 2009-12-31 | 11.43% |
| 2009-09-30 | 16.48% |
| 2009-06-30 | 14.26% |
| 2009-03-31 | 15.90% |
| 2008-12-31 | 20.41% |
| 2008-09-30 | 16.33% |
| 2008-06-30 | 6.22% |
| 2008-03-31 | 15.39% |
| 2007-12-31 | 11.38% |
| 2007-09-30 | 12.38% |
| 2007-06-30 | 14.02% |
| 2007-03-31 | 16.18% |
| 2006-12-31 | 17.32% |
| 2006-09-30 | 15.00% |
| 2006-06-30 | 12.28% |
| 2006-03-31 | 9.71% |
| 2005-12-31 | 2.57% |
| 2005-09-30 | 4.97% |
| 2005-06-30 | 3.98% |
| 2005-03-31 | 0.51% |
| 2004-12-31 | 3.94% |
| 2004-09-30 | 4.63% |
| 2004-06-30 | 6.02% |
| 2004-03-31 | 8.21% |
| 2003-12-31 | 0.25% |
| 2003-09-30 | 0.35% |
| 2003-06-30 | 0.42% |
| 2003-03-31 | 0.89% |
| 2002-12-31 | 3.12% |
| 2002-09-30 | 3.89% |
